These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28368960)

  • 21. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
    Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
    Moore TV; Lyons GE; Brasic N; Roszkowski JJ; Voelkl S; Mackensen A; Kast WM; Le Poole IC; Nishimura MI
    Cancer Immunol Immunother; 2009 May; 58(5):719-28. PubMed ID: 18836717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaccines for the treatment of non-small cell lung cancer].
    Leduc C; Quoix E
    Rev Mal Respir; 2019 Mar; 36(3):415-425. PubMed ID: 30902445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
    Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
    Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I Trial of Intratumoral Injection of
    Lee JM; Lee MH; Garon E; Goldman JW; Salehi-Rad R; Baratelli FE; Schaue D; Wang G; Rosen F; Yanagawa J; Walser TC; Lin Y; Park SJ; Adams S; Marincola FM; Tumeh PC; Abtin F; Suh R; Reckamp KL; Lee G; Wallace WD; Lee S; Zeng G; Elashoff DA; Sharma S; Dubinett SM
    Clin Cancer Res; 2017 Aug; 23(16):4556-4568. PubMed ID: 28468947
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model.
    Yazdani M; Nikpoor AR; Gholizadeh Z; Mohamadian Roshan N; Seifalian A; Jaafari MR; Badiee A
    Int Immunopharmacol; 2021 Sep; 98():107833. PubMed ID: 34352472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
    Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.
    Bossi G; Buisson S; Oates J; Jakobsen BK; Hassan NJ
    Cancer Immunol Immunother; 2014 May; 63(5):437-48. PubMed ID: 24531387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.
    Abdel-Wahab Z; DeMatos P; Hester D; Dong XD; Seigler HF
    Cell Immunol; 1998 May; 186(1):63-74. PubMed ID: 9637766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.
    Leaf RK; Stroopinsky D; Pyzer AR; Kruisbeek AM; van Wetering S; Washington A; Ephraim A; Cole L; Morin A; Jain S; Nahas MR; Apel A; Arnason J; Hamdan A; Rosenblatt J; Avigan D
    J Immunother; 2017; 40(9):315-322. PubMed ID: 28961609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL.
    Wolfraim LA; Takahara M; Viley AM; Shivakumar R; Nieda M; Maekawa R; Liu LN; Peshwa MV
    Int Immunopharmacol; 2013 Mar; 15(3):488-97. PubMed ID: 23474736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-A(*)0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients.
    Aspord C; Leccia MT; Salameire D; Laurin D; Chaperot L; Charles J; Plumas J
    J Invest Dermatol; 2012 Oct; 132(10):2395-2406. PubMed ID: 22696054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles).
    Xing Y; Cao R; Hu HM
    Cell Death Dis; 2016 Aug; 7(8):e2322. PubMed ID: 27490927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusion of the Human Cytomegalovirus pp65 antigen with both ubiquitin and ornithine decarboxylase additively enhances antigen presentation to CD8(+) T cells in human dendritic cells.
    Park MJ; Kim EK; Han JY; Cho HW; Sohn HJ; Kim SY; Kim TG
    Hum Gene Ther; 2010 Aug; 21(8):957-67. PubMed ID: 20218861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
    von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
    J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses.
    Zhou Y; McEarchern JA; Howard E; Pestano G; Salgaller ML; Bosch ML
    Cancer Immunol Immunother; 2003 Jul; 52(7):413-22. PubMed ID: 12835918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction.
    Palmer DC; Balasubramaniam S; Hanada K; Wrzesinski C; Yu Z; Farid S; Theoret MR; Hwang LN; Klebanoff CA; Gattinoni L; Goldstein AL; Yang JC; Restifo NP
    J Immunol; 2004 Dec; 173(12):7209-16. PubMed ID: 15585842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inducing efficient cross-priming using antigen-coated yeast particles.
    Howland SW; Tsuji T; Gnjatic S; Ritter G; Old LJ; Wittrup KD
    J Immunother; 2008 Sep; 31(7):607-19. PubMed ID: 18600183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.